ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : Therapeutic commitment
Field of Research : Biomedical Engineering
Clear All
Filter by Field of Research
Biomedical Engineering (4)
Therapies And Therapeutic Technology (4)
Biomechanical Engineering (2)
Medical Biotechnology (2)
Biomaterials (1)
Biomedical Engineering Not Elsewhere Classified (1)
Computer-Human Interaction (1)
Polymers (1)
Filter by Socio-Economic Objective
Computer software and services not elsewhere classified (2)
Immune system and allergy (2)
Respiratory system and diseases (incl. asthma) (2)
Health and support services not elsewhere classified (1)
Health status (e.g. indicators of “well-being”) (1)
Medical instrumentation (1)
Mental health (1)
Other (1)
Treatments (e.g. chemicals, antibiotics) (1)
Filter by Funding Provider
Australian Research Council (4)
Filter by Status
Closed (4)
Filter by Scheme
Linkage Projects (3)
Discovery Projects (1)
Filter by Country
Australia (4)
Filter by Australian State/Territory
VIC (3)
NSW (1)
  • Researchers (4)
  • Funded Activities (4)
  • Organisations (4)
  • Funded Activity

    Discovery Projects - Grant ID: DP0664805

    Funder
    Australian Research Council
    Funding Amount
    $260,000.00
    Summary
    Development of Acid Degradable Polymeric Nanoparticles for Intracellular and Tumour Site Selective Delivery of Drugs. There is an enormous need to develop effective anticancer drug delivery systems to reduce the social and economic impact of cancer. One of the most critical problems in tumour treatment is the lack of selective toxicity of anticancer drugs against tumour tissues. Our multidisciplinary team will aim to develop a novel polymer based system for tumour site-selective delivery of anti .... Development of Acid Degradable Polymeric Nanoparticles for Intracellular and Tumour Site Selective Delivery of Drugs. There is an enormous need to develop effective anticancer drug delivery systems to reduce the social and economic impact of cancer. One of the most critical problems in tumour treatment is the lack of selective toxicity of anticancer drugs against tumour tissues. Our multidisciplinary team will aim to develop a novel polymer based system for tumour site-selective delivery of anticancer drugs. Development of such advanced drug delivery systems will significantly enhance Australia`s power in biotechnology. Development and/or formation of strategies to improve the health quality of Australians, is an important anticipated outcome of this innovative project.
    Read more Read less
    More information
    Funded Activity

    Linkage Projects - Grant ID: LP0562562

    Funder
    Australian Research Council
    Funding Amount
    $120,000.00
    Summary
    Design and Development of a Low-Cost Portable Biofeedback Device for use in Sleep Induction and Relaxation. This project aims to expand on existing knowledge of the various stimuli used in sleep induction such as photic, auditory and weak electromagnetic stimulation and develop a low-cost portable biofeedback prototype. This novel device will be based on adaptive or fuzzy reasoning algorithms, which would be integrated into the existing ambulatory Siesta EEG recording system, produced by Compume .... Design and Development of a Low-Cost Portable Biofeedback Device for use in Sleep Induction and Relaxation. This project aims to expand on existing knowledge of the various stimuli used in sleep induction such as photic, auditory and weak electromagnetic stimulation and develop a low-cost portable biofeedback prototype. This novel device will be based on adaptive or fuzzy reasoning algorithms, which would be integrated into the existing ambulatory Siesta EEG recording system, produced by Compumedics Ltd. The development of this novel real-time biofeedback prototype will encourage further research using this particular technology to apply it in preventative healthcare in Australian community. The outcome of this proposed bioinstrumentation prototype could possibly expand sleep market to new international level.
    Read more Read less
    More information
    Funded Activity

    Linkage Projects - Grant ID: LP0561870

    Funder
    Australian Research Council
    Funding Amount
    $150,000.00
    Summary
    Drug particle characterisation. The understanding of drug particle characterizations is one of the key issues in the development of novel nasal sprayers for targeted drug delivery. A comprehensive study is proposed for characterising drug formation in sprayers and particle deposition in nasal cavity using the latest experimental and numerical techniques. A computer-aided design technology will be developed to optimise drug delivery systems. The new technology has great potentials leading to the .... Drug particle characterisation. The understanding of drug particle characterizations is one of the key issues in the development of novel nasal sprayers for targeted drug delivery. A comprehensive study is proposed for characterising drug formation in sprayers and particle deposition in nasal cavity using the latest experimental and numerical techniques. A computer-aided design technology will be developed to optimise drug delivery systems. The new technology has great potentials leading to therapeutic and economic benefits in developing advanced/innovative drug delivery systems and in evaluating the potential biological effects by the drugs to be introduced through the nose.
    Read more Read less
    More information
    Funded Activity

    Linkage Projects - Grant ID: LP0455020

    Funder
    Australian Research Council
    Funding Amount
    $70,668.00
    Summary
    OPTIMIZED NASAL DRUG DELIVERY SYSTEMS -- COMPUTER AIDED DESIGN. The aim of this project is to develop a computer-aided design technology to assist in targeted drug delivery through the human nasal cavity which is being recognised to be an excellent alternative route for the administration of medication drugs. The aim will be achieved by conducting computer modelling of nasal flow under realistic physiological conditions and by performing experimental measurements and testing to validate computer .... OPTIMIZED NASAL DRUG DELIVERY SYSTEMS -- COMPUTER AIDED DESIGN. The aim of this project is to develop a computer-aided design technology to assist in targeted drug delivery through the human nasal cavity which is being recognised to be an excellent alternative route for the administration of medication drugs. The aim will be achieved by conducting computer modelling of nasal flow under realistic physiological conditions and by performing experimental measurements and testing to validate computer models. The new technology has great potentials leading to therapeutic and economical benefits in developing advanced/innovative drug delivery systems and in evaluating the potential biological effects by the drugs to be introduced through the nose.
    Read more Read less
    More information

    Showing 1-4 of 4 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback